Adults with plaque PsO who received continuous icotrokinra had superior efficacy outcomes when compared with those who switched to placebo.

Delgocitinib cream 20mg/g significantly improves the sign and symptoms of chronic hand eczema among adolescent patients compared with vehicle cream.

Topical ruxolitinib cream 1.5% for 24 weeks was significantly associated with disease improvement among patients with prurigo nodularis.

High doses of temtokibart — including 600 mg, 450 mg, and 300 mg — contributed to significant improvements in disease severity in patients with AD.

Levels of systemic inflammatory markers were reduced following 16 weeks of secukinumab treatment in patients with moderate to severe HS.

HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online Sept. 3 in JAMA Network ...

The time to onset of action was fastest with IL-17 inhibitors, followed by IL-23, IL-12/23, then PDE-4 and JAK inhibitors for ...

Theoretically ending Ryan White services for 5 years was estimated to result in 75,436 additional HIV infections.

The FDA is regulating direct-to-consumer drug advertisements to ensure "fair balance" of information on pharmaceutical products.

The United States contributed more than half of global public and philanthropic cancer research funding between 2016 and 2023.

The American Academy of Family Physicians has released its fall immunization recommendations for COVID-19, RSV, and influenza.

No significant differences in outcomes were observed among those with melanoma who had transected vs nontransected tumors when stratified by T stage.